Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Analysis of Remote Electrical Neuromodulation (REN) for the Acute Treatment of Migraine

NCT04992897 is registered in ClinicalTrials.gov with Theranica as lead sponsor.

NCT NCT04992897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04992897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Analysis of Remote Electrical Neuromodulation (REN) for the Acute Treatment of Migraine
Lead sponsor
Theranica
Phase
Observational
Overall status
Completed
Start date
June 15, 2021
Completion date
August 10, 2021
Enrollment
12,151 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

migraine